REFRACTORY LEUKEMIA

Clinical trials for REFRACTORY LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for kids with relapsed cancer: drug combo shows promise in early trial

Disease control Completed

This early-phase study tested a three-drug combination (carfilzomib, cyclophosphamide, and etoposide) in 4 children whose solid tumors or leukemias had returned or were not responding to standard treatments. The main goal was to find the safest dose and identify side effects. The…

Matched conditions: REFRACTORY LEUKEMIA

Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control

Last updated May 11, 2026 20:47 UTC

REFRACTORY LEUKEMIA

Get alerted when new REFRACTORY LEUKEMIA trials appear

New hope for kids with relapsed cancer: drug combo shows promise in early trial